Epstein David R bought 4,960 shares of AgomAb Therapeutics NV at $6.02 for $29.9k on Nov 13, 2026

Buy
Form 4 code P. Open-market or private purchase of a non-derivative or derivative security.
Director
DIR
Filed Nov 16, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
$29,859.20Shares × reported price
Shares traded
4,960Common shares
Price per share
$6.02Reported price. Read footnotes for ranges.
% of reported position traded
9.92%This security and ownership context
Holdings after
54,980Direct
Trade date
Nov 13, 2026Buy
Filed
Nov 16, 2026, 6:43 AM ET3-day reporting delay
Accession
0001445826-26-000019Code P · Transaction 401659
How reported position traded is calculated

Shares purchased ÷ (holdings after − shares purchased). Estimated position before: 50,020 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Nov 13, 2026Buy5,000$5.99$29,950Trade 401656
Nov 13, 2026Buy20$6.00$120Trade 401657
Nov 13, 2026Buy5,000$5.75$28,750Trade 401658
4 transaction rows in this filing. Joint filers share the same rows.

AGMB price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
AGMB · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.

Return windows are pending. The first 7-day window is eligible on Nov 23, 2026. Values appear when the daily price refresh supplies a valid close for that window. Weekends, market holidays and missing prices can delay updates.

Pre-filing1mo ago +37%1w ago +20%1d ago 0%
Returns since7d30d90d180d1y

Footnotes in full

F1: The common shares may be represented by American Depositary Shares, each of which currently represents one common share.